Market Highlights
According to MRFR analysis, the global pharmaceutical gelatin market is expected to register a CAGR of 6.4% from 2022 to 2030 and hold a value of USD 1,595.8 million by 2030.
The global pharmaceutical gelatin market is driven by several factors, such as rising use of gelatin in medical & biomedical applications and growing demand for regenerative medicine. In addition, the increasing popularity of fortified gummies as an alternative delivery system for minerals & vitamins is further boost the growth of the market. Moreover, technological advancements to reduce the amount of cross-linking of gelatin in the capsule and enhance its shelf life, is fueling the growth of the pharmaceutical gelatin market during the forecast period.
The key players are involved in product launches, strategic agreements, joint ventures, and acquisitions to augment their market positions. For instance, in September 2018, Avet Pharmaceuticals Inc. (US) launched Ethosuximide (250mg) Soft Gelatin Capsules. This new product launch will strengthen its product portfolio and boost the demand of pharmaceutical gelatin, ultimately fuels the growth of the pharmaceutical gelatin market.
Regional Analysis
North America is expected to dominate the pharmaceutical gelatin market, owing to rising prevalence of chronic diseases and growing application of pharmaceutical gelatin such as stabilizer, absorbable hemostats, and others in pharmaceutical industry. Furthermore, the presence of major industry players across the region, such as Darling Ingredients Inc. (US), Aspire Pharmaceuticals (US), Norland Products Inc. (US), and others are dominating the global pharmaceutical gelatin market.
Europe is expected to hold a significant share in the pharmaceutical gelatin market due to wide availability of raw materials such as porcine & bovine and growing demand for pharmaceutical gelatin in the pharmaceutical and biotechnology industry across the region. Furthermore, rising pharmaceutical R&D investments is also expected to boost market growth.
Asia-Pacific is anticipated to be the fastest-growing regional market during the forecast period, due to rising investment in healthcare infrastructure, increasing number of contract research & manufacturing companies in the region. In addition, global key players’ initiatives to expand operations in the Asia-Pacific, due to lower labor & capital costs for the manufacturing of pharmaceutical gelatin are also boosts the market growth.
Furthermore, the growth of the pharmaceutical gelatin market in the rest of the world is driven by rising government initiatives for improving the healthcare sector and the growing number of pharmaceutical & biotechnology industries. Moreover, rising applications of pharmaceutical gelatin for anticancer drugs delivery, gene delivery, and other applications in pharmaceutical companies is also boosting the growth of the market.
Segmentation
The global pharmaceutical gelatin market has been segmented into source, function, application, and type.
Based on source, the market has been segmented into porcine, bovine skin, animal bones, and others. The porcine segment held a larger market share in 2021, due to the increasing applications in the pharmaceutical industry such as absorbable hemostats, coating for tablets and other biomedical applications. In addition, lower production costs and a shorter manufacturing cycle, are also driving the expansion of this segment.
Based on function, the market has been segmented into stabilizer, thickener, gelling agent, and others. The thickener segment held the highest share in 2021, due to its rising application in medicinal syrups, elixirs, and other liquid dosage forms
Based on application, the market has been segmented into hard capsules, soft capsules, micro-encapsulation, coating for tablets, and absorbable hemostat, and others.
Based on type, the market has been bifurcated into type A, and type B.
Key Players
The global pharmaceutical gelatin market players are Darling Ingredients Inc. (US), Nitta Gelatin Inc. (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt International (France), Trobas Gelatine B.V. (Netherlands), Lonza Group AG (Switzerland), Lapi Gelatine S.p.A (Italy), Italgelatine S.p.A (Italy), Xiamen Gelken Gelatin Co. Ltd. (China), Gelco International (Brazil), Aspire Pharmaceuticals (US), India Gelatine & Chemicals Ltd. (India), Gelnex Industria E Comercio Ltda (Brazil), Henan Boom Gelatin Co. Ltd (China), Baotou Dongbao Bio-Tech Co. Ltd (China), Norland Products Inc. (US), Geltech Co. Ltd (South Korea), Geliko LLC (US), and Kenney & Ross Limited (Canada
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
